Drug Makers Present Cases in Which PI Trials in Japanese Could Be Omitted in Multinational Studies: PMDA Workshop

The Pharmaceuticals and Medical Devices Agency (PMDA) held a workshop on December 15 for the pharmaceutical industry on the need for PI clinical studies in Japanese subjects prior to initiating multinational clinical trials including Japanese patients. A related administrative communication...read more